Indications and outcome of splenectomy in hematologic disease - 08/12/17
páginas | 9 |
Iconografías | 0 |
Vídeos | 0 |
Otros | 0 |
Summary |
Splenectomy is part of the therapeutic arsenal for benign or malignant hematological disorders that constitute the main indication for elective splenectomy. With the development of minimally invasive approaches, and in particular, laparoscopy, as well as the advent of monoclonal antibody therapy, the indications and the outcomes of splenectomy for hematologic disease have changed in recent years. Nonetheless, splenectomy has its place in hemoglobinopathies and hemolytic diseases, improves thrombocytopenia in refractory immune thrombocytopenic purpura, can reverse sequelae linked to voluminous splenomegaly secondary to myelofibrosis, or can be used for diagnostic purposes or for splenomegaly in lymphoproliferative syndromes.
El texto completo de este artículo está disponible en PDF.Keywords : Splenectomy, Hematology, Splenomegaly, Hypersplenism, Hemolysis, Myeloproliferative syndrome, Lymphoproliferative syndrome
Esquema
Vol 154 - N° 6
P. 421-429 - décembre 2017 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?